Do all aromatase inhibitors have similar efficacy and safety?
作者信息
Şendur Mehmet An, Bilgin Burak, Hızal Mutlu, Özdemir Nuriye Yıldırım, Akıncı Muhammed Bülent, Dede Didem Şener, Yalçın Bulent
机构信息
Department of Medical Oncology, Faculty of Medicine, Yıldırım Beyazıt University, Bilkent, Ankara 06800, Turkey.
出版信息
Future Oncol. 2017 Aug;13(19):1673-1676. doi: 10.2217/fon-2017-0228. Epub 2017 Aug 23.
PMID:28831832
Abstract
摘要
相似文献
1
Do all aromatase inhibitors have similar efficacy and safety?所有芳香化酶抑制剂的疗效和安全性都相似吗？
Future Oncol. 2017 Aug;13(19):1673-1676. doi: 10.2217/fon-2017-0228. Epub 2017 Aug 23.
2
Adjuvant endocrine therapy for breast cancer: don't ditch the switch!乳腺癌的辅助内分泌治疗：不要放弃转换治疗！
J Natl Cancer Inst. 2011 Sep 7;103(17):1280-2. doi: 10.1093/jnci/djr302. Epub 2011 Aug 22.
3
Switch to exemestane effective in early breast cancer.改用依西美坦对早期乳腺癌有效。
Lancet Oncol. 2017 Jun;18(6):e308. doi: 10.1016/S1470-2045(17)30341-8. Epub 2017 May 11.
4
Switching to aromatase inhibitors in early breast cancer.早期乳腺癌改用芳香化酶抑制剂。
Lancet. 2007 Feb 17;369(9561):533-5. doi: 10.1016/S0140-6736(07)60201-3.
5
Exemestane or tamoxifen?依西美坦还是他莫昔芬？
Lancet. 2007 May 12;369(9573):1600; author reply 1600-1. doi: 10.1016/S0140-6736(07)60741-7.
6
Hormonal therapy for advanced breast cancer.晚期乳腺癌的激素治疗
Hematol Oncol Clin North Am. 2007 Apr;21(2):273-91. doi: 10.1016/j.hoc.2007.03.007.
7
[Endocrine and cytostatic therapies in patients with breast cancer].[乳腺癌患者的内分泌治疗与细胞毒性治疗]
MMW Fortschr Med. 2008 Jan 17;150(1-2):29-31, 33. doi: 10.1007/BF03365275.
8
Cancer: some reasons to be hopeful.癌症：一些充满希望的理由。
Lancet. 2007 Feb 17;369(9561):531. doi: 10.1016/S0140-6736(07)60243-8.
9
The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer.芳香化酶抑制剂在早期乳腺癌治疗中不断演变的作用。
Nat Clin Pract Oncol. 2005 Dec;2(12):596-7. doi: 10.1038/ncponc0360.
10
When should we give aromatase inhibitors for insomnia; early in the day or after dinner?我们应该在什么时候服用芳香化酶抑制剂来治疗失眠，是在一天中的早些时候还是晚餐后？
J BUON. 2016 Mar-Apr;21(2):521.
引用本文的文献
1
Interaction of letrozole and its degradation products with aromatase: chemometric assessment of kinetics and structure-based binding validation.来曲唑及其降解产物与芳香化酶的相互作用：基于化学计量学的动力学评估和基于结构的结合验证。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1600-1609. doi: 10.1080/14756366.2022.2081845.
Zotero 插件